Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Combining multiple ingredients is the most effective treatment for hyperpigmentation.

Targeting the p300/AR axis may help treat polycystic ovary syndrome.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Valproic acid helps hair follicle stem cells survive better in low oxygen and glucose conditions.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

Targeting DNA methylation can help treat skin disorders and cancers.

Baricitinib is effective and safe for treating severe alopecia areata.

Tamsulosin increases the risk of floppy iris during eye surgery.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

More research is needed to find the best long-term treatments for Alopecia Areata.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Certain substances can protect against ear damage from some antibiotics in zebrafish.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

New treatments for child hair loss due to immune issues are effective but not yet officially approved.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Different drugs are used to manage breeding, prevent or end pregnancy, and treat reproductive issues in dogs and cats.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.